-
公开(公告)号:UY26684A1
公开(公告)日:2001-11-30
申请号:UY26684
申请日:2001-04-25
Applicant: ABBOTT LAB
Inventor: WANG WEI-BO , II STEPHEN L GWALTNEY , LI QUIN , CONNOR STEPHEN J O , WANG GARY T , CURTIN MICHAEL L , HASVOLD LISA A , LIN NAN-HORNG , SHAM HING L , WANG XILU , FAKHOURY STEPHEN A , HUTCHINS CHARLES W , JENNINGS LISSA TAKA , SULLIVAN GERARD M
Abstract: Compuestos de la fórmula (I) o una sal del mismo aceptable para el uso farmacéutico que inhiben la farnesiltransferasa. Métodos para preparar los compuestos, composiciones de uso farmacéutico que contienen los compuestos, y métodos de tratamiento que usan los compuestos.
-
公开(公告)号:AT206390T
公开(公告)日:2001-10-15
申请号:AT96912978
申请日:1996-04-18
Applicant: ABBOTT LAB
Inventor: ARENDSEN DAVID L , BAKER WILLIAM R , FAKHOURY STEPHEN A , FUNG K L ANTHONY , GARVEY DAVID S , MCCLELLAN WILLIAM J , O'CONNOR STEPHEN J , PRASAD RAJNANDAN N , ROCKWAY TODD W , ROSENBERG SAUL H , STEIN HERMAN H , SHEN WANG , STOUT DAVID M , SULLIVAN GERARD M , AUGERI DAVID J
IPC: A61K31/195 , A61K31/215 , A61K31/38 , A61K31/381 , A61K31/41 , A61K31/4245 , A61K31/433 , A61P3/06 , A61P9/00 , A61P9/08 , A61P31/04 , A61P35/00 , A61P43/00 , C07C233/58 , C07C233/59 , C07C233/60 , C07C235/40 , C07C235/82 , C07D271/06 , C07D271/10 , C07D285/10 , C07D333/20 , A61K31/19
Abstract: The present invention provides a compound of formula (II) or a pharmaceutically acceptable salt thereof, which is useful for inhibiting protein farnesyltransferase and the farnesylation of the oncogene protein Ras, processes for the preparation of the compounds of the invention in addition to intermediates useful in these processes, a pharmaceutical composition, and to methods of using such compounds.
-
公开(公告)号:DK0677039T3
公开(公告)日:1999-09-27
申请号:DK94931987
申请日:1994-10-20
Applicant: ABBOTT LAB
Inventor: BAKER WILLIAM R , DONNER B GREGORY , FAKHOURY STEPHEN A , FUNG ANTHONY K L , GARVEY DAVID S , O'CONNOR STEPHEN J , PRASAD RAJNANDAN , ROCKWAY TODD W , ROSENBERG SAUL H , SHEN WANG , STOUT DAVID M , SULLIVAN GERARD M
IPC: C12N9/99 , A61K31/195 , A61K31/215 , A61K31/34 , A61K31/341 , A61K31/357 , A61K31/36 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/41 , A61K31/42 , A61K31/421 , A61K31/4245 , A61K31/44 , A61K31/4409 , A61K31/4418 , A61P3/06 , A61P7/00 , A61P9/10 , A61P31/04 , A61P43/00 , C07C69/52 , C07C69/74 , C07C231/02 , C07C233/19 , C07C233/58 , C07C233/59 , C07C233/60 , C07C233/61 , C07C233/62 , C07C233/63 , C07C235/36 , C07C235/40 , C07C237/24 , C07C245/14 , C07C251/42 , C07C259/08 , C07C275/26 , C07C311/51 , C07C323/40 , C07C323/46 , C07C327/20 , C07C327/36 , C07C327/38 , C07D207/325 , C07D213/40 , C07D257/04 , C07D257/06 , C07D263/24 , C07D271/06 , C07D271/10 , C07D277/20 , C07D277/34 , C07D285/16 , C07D285/18 , C07D307/42 , C07D307/52 , C07D309/32 , C07D317/60 , C07D319/06 , C07D333/08 , C07D333/58 , A61K31/16
-
44.
公开(公告)号:CA2744711C
公开(公告)日:2017-06-27
申请号:CA2744711
申请日:2009-12-04
Applicant: ABBOTT LAB
Inventor: BRUNCKO MILAN , DING HONG , DOHERTY GEORGE A , ELMORE STEVEN W , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , MANTEI ROBERT A , MCCLELLAN WILLIAM J , PARK CHANG H , PARK CHEOL-MIN , PETROS ANDREW M , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL D
IPC: C07D405/12 , A61K31/404 , A61P35/00 , C07D209/32 , C07D211/96 , C07D213/64 , C07D215/20 , C07D217/16 , C07D235/26 , C07D249/04 , C07D295/125 , C07D295/14 , C07D309/14 , C07D401/12
Abstract: Disclosed are compounds of formula (I) which inhibit the activity of anti-apoptotic BcI -2 or BcI -xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti -aooptotic Bcl-2 protein.
-
45.
公开(公告)号:SG193849A1
公开(公告)日:2013-10-30
申请号:SG2013066071
申请日:2010-01-15
Applicant: ABBOTT LAB
Inventor: HEXAMER LAURA , DING HONG , ELMORE STEVEN W , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WENDT MICHAEL D
Abstract: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES5 Disclosed are compounds of formula (I) which inhibit the activity of anti-apoptotic Bel-2proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bc1-2 protein. No suitable figure
-
公开(公告)号:CA2515790C
公开(公告)日:2012-11-27
申请号:CA2515790
申请日:2004-02-26
Applicant: ABBOTT LAB
Inventor: HASVOLD LISA A , HEXAMER LAURA , LI GAOQUAN , LIN NAN-HORNG , SHAM HING , SOWIN TOM , SULLIVAN GERARD M , WANG LE , XIA PING XIA
IPC: C07D243/38 , A61K31/551 , A61P35/00 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/12 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/06 , C07D413/10 , C07D413/12 , C07D417/04 , C07D417/12 , C07D491/10
Abstract: Compounds having the formula (I) are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
-
公开(公告)号:CR20120346A
公开(公告)日:2012-09-03
申请号:CR20120346
申请日:2012-06-25
Applicant: ABBOTT LAB
Inventor: BRUNCKO MILAN , DING HONG , DOHERTY GEORGE A , ELMORE STEVEN W , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON , MANTEI ROBERT A , MCCLELLAN WILLIAM J , PETROS ANDREW M , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL D , HANSEN TODD M , SONG XIAOHONG , PARK CHANG H , PARK CHEOL-MIN
IPC: C07D405/12 , A61K31/404 , A61P35/00 , C07D209/32 , C07D211/96 , C07D213/64 , C07D215/20 , C07D217/16 , C07D231/56 , C07D235/26 , C07D249/04 , C07D295/125 , C07D295/14 , C07D309/14 , C07D401/12 , C07D405/14
Abstract: Compuestos que inhiben la actividad de las proteínas anti-apoptóticas Bcl-2 o Bcl-XL, composiciones que contienen dichos compuestos y métodos para tratar enfermedades durante las cuales se expresa la proteína anti-apoptótica Bcl-2.
-
公开(公告)号:ECSP12012017A
公开(公告)日:2012-08-31
申请号:ECSP12012017
申请日:2012-07-03
Applicant: ABBOTT LAB
Inventor: HASVOLD LISA A , SULLIVAN GERARD M , WANG GARY , WANG XILU , MANTEI ROBERT A , ELMORE STEVEN W , SOUERS ANDREW J , BRUNCKO MILAN , SONG XIAOHONG , WANG LE , KUNZER AARON R , PARK CHEOL-MIN , WENDT MICHAEL D , TAO ZHI-FU , DING HONG , HEXAMER LAURA , MCCLELLAN WILLIAM J , PARK CHANG H , PETROS ANDREW M , HANSEN TODD M , DOHERTY GEORGE A
IPC: C07D405/12 , A61K31/404 , A61P35/00 , C07D209/32 , C07D213/64 , C07D215/20 , C07D217/16 , C07D231/56 , C07D235/26 , C07D249/04 , C07D295/125 , C07D295/14 , C07D309/14 , C07D401/12 , C07D405/14
Abstract: Compuestos que inhiben la actividad de las proteínas anti-apoptóticas Bcl-2 o Bcl-XL, composiciones que contienen dichos compuestos y métodos para tratar enfermedades durante las cuales se expresa la proteína anti-apoptótica Bcl-2.
-
49.
公开(公告)号:MX2012006391A
公开(公告)日:2012-06-19
申请号:MX2012006391
申请日:2010-06-01
Applicant: ABBOTT LAB
Inventor: WANG GARY T , HEXAMER LAURA , SULLIVAN GERARD M , WANG LE , TAO ZHI-FU , BRUNCKO MILAN , WENDT MICHAEL D , DAI YUJIA , DING HONG , ELMORE STEVEN W , MCCELLAN WILLIAM J , HANSEN TODD M , SOUERS ANDREW J , SONG XIAOHONG , PARK CHEOL-MIN , MANTEI ROBERT A , DOHERTY GEORGE A , HASVOLD LISA , PARK CHANG H , PETROS ANDREW M , KUNZER AARON
IPC: C07D209/08 , C07D211/58 , C07D213/74 , C07D213/84 , C07D231/56 , C07D235/06 , C07D277/24 , C07D309/04 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/12 , C07D417/12 , C07D471/04
Abstract: Se describen los compuestos que inhiben la actividad de las proteínas anti-apoptóticas BcI-2, las composiciones que contienen los compuestos, y los métodos para tratar las enfermedades durante las cuales se expresa la proteína anti-apoptótica Bcl-2.
-
50.
公开(公告)号:ECSP11011554A
公开(公告)日:2012-01-31
申请号:ECSP11011554
申请日:2011-12-26
Applicant: ABBOTT LAB
Inventor: DOHERTY GEORGE ANDREW , HASVOLD LISA A , SULLIVAN GERARD M , WANG XILU , MANTEI ROBERT A , ELMORE STEVEN W , SOUERS ANDREW J , BRUNCKO MILAN , SONG XIAOHONG , WANG LE , KUNZER AARON R , WENDT MICHAEL D , TAO ZHI-FU , DING HONG , HEXAMER LAURA , HANSEN TODD M
IPC: C07D471/04 , A61K31/437 , A61P35/00
Abstract: Compuestos que inhiben la actividad de proteínas anti-apoptóticas Bcl-2, composiciones que contienen a dichos compuestos y métodos de tratamiento de enfermedades durante cuyo transcurso hay expresión de la proteína anti-apoptótica Bcl-2.
-
-
-
-
-
-
-
-
-